Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Assets: 2024-2025

Historic Assets for Pyxis Oncology (PYXS) over the last 2 years, with Sep 2025 value amounting to $105.6 million.

  • Pyxis Oncology's Assets fell 45.93% to $105.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $105.6 million, marking a year-over-year decrease of 45.93%. This contributed to the annual value of $157.2 million for FY2024, which is N/A change from last year.
  • As of Q3 2025, Pyxis Oncology's Assets stood at $105.6 million, which was down 14.29% from $123.2 million recorded in Q2 2025.
  • In the past 5 years, Pyxis Oncology's Assets ranged from a high of $220.2 million in Q1 2024 and a low of $105.6 million during Q3 2025.
  • Over the past 2 years, Pyxis Oncology's median Assets value was $157.2 million (recorded in 2024), while the average stood at $163.7 million.
  • Data for Pyxis Oncology's Assets shows a maximum YoY plummeted of 45.93% (in 2025) over the last 5 years.
  • Over the past 2 years, Pyxis Oncology's Assets (Quarterly) stood at $157.2 million in 2024, then plummeted by 45.93% to $105.6 million in 2025.
  • Its last three reported values are $105.6 million in Q3 2025, $123.2 million for Q2 2025, and $135.9 million during Q1 2025.